◆ 会议时间：2022年9月21,22,28,29日
◆ 会议地点：Virtual
◆ 会议简介：
2022年第14届RIVKIN-AACR卵巢癌研究研讨会/双年会议将于2022年9月21,22,28,29日举行，会议由Rivkin卵巢癌研究中心与美国癌症研究协会(AACR)联合组织，每两年举办一次。研讨会的目的是召集来自世界各地不同学科和机构的临床医生和研究人员，以促进合作，推动卵巢癌研究领域的发展。会议旨在增进对卵巢癌的了解和认识，特别是针对初级研究人员；讨论卵巢癌研究领域的最新创新；并解决临床和研究界领导人迫切关注的问题。会议议题将包括：DNA修复及其机制；免疫肿瘤学；模型系统；新型疗法；预防和早期发现；罕见肿瘤。未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)
14th Biennial Ovarian Cancer Research Symposium
Date: 21,22,28,29 September 2022
Venue: Virtual
The 14th Biennial Ovarian Cancer Research Symposium will take place in the form of a Virtual Seminar Series that will provide an educational opportunity and keep our community connected. The goal of the Seminar Series is to bring together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research. The Seminars seek to enhance the understanding and knowledge of ovarian cancer, discuss the most recent innovations in the field of ovarian cancer research, and address pressing concerns of the leaders in the clinical and research community.
The Seminar topics were developed by our Planning Committee and each Seminar will feature invited lectures by experts in the field, as well as Lightning Round talks from selected abstracts. Abstracts not selected for the Lightning Round talks may be invited to submit a virtual poster. AMA PRA Category 1 Credit(s)TM will be offered for the live, virtual activity. Registration will cover all four Seminars; you cannot register for individual Seminars. For registrants who are unable to join us live, recordings of the Seminars will be made available OnDemand for 90 days on the AACR website.
Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM available. Visit the CME tab for more information.
SEMINAR TOPICS
- Precision Medicine
- Immuno-oncology
- Prevention and Early Detection
- Healthcare Disparities and Patient Advocacy
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
